Eric Hughes - Executive Vice President, Global R&D and Chief Medical Officer at Teva Pharmaceutical Industries Ltd

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President, Global R&D and Chief Medical Officer
Stock Symbol
TEVA on NYSE, TEVJF on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Eric Hughes - trading volume in the past year for Teva Pharmaceutical Industries Ltd

Holdings reported by Eric Hughes for Teva Pharmaceutical Industries Ltd

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Ordinary Shares 16,855 $225 K $13.34 Mar 4, 2024 Direct
Restricted Share Units 93,005 Mar 4, 2024 Direct Ordinary Shares

Transactions reported by Eric Hughes for Teva Pharmaceutical Industries Ltd

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership